240 related articles for article (PubMed ID: 27925349)
21. Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons.
Auma AWN; Shive CL; Lange A; Damjanovska S; Kowal C; Zebrowski E; Pandiyan P; Wilson B; Kalayjian RC; Canaday DH; Anthony DD
Front Immunol; 2021; 12():641230. PubMed ID: 33912168
[TBL] [Abstract][Full Text] [Related]
22. Infection history determines the differentiation state of human CD8+ T cells.
van Aalderen MC; Remmerswaal EB; Verstegen NJ; Hombrink P; ten Brinke A; Pircher H; Kootstra NA; ten Berge IJ; van Lier RA
J Virol; 2015 May; 89(9):5110-23. PubMed ID: 25717102
[TBL] [Abstract][Full Text] [Related]
23. Role of CD11c
Karnell JL; Kumar V; Wang J; Wang S; Voynova E; Ettinger R
Cell Immunol; 2017 Nov; 321():40-45. PubMed ID: 28756897
[TBL] [Abstract][Full Text] [Related]
24. Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.
Ravens S; Hengst J; Schlapphoff V; Deterding K; Dhingra A; Schultze-Florey C; Koenecke C; Cornberg M; Wedemeyer H; Prinz I
Front Immunol; 2018; 9():510. PubMed ID: 29616028
[TBL] [Abstract][Full Text] [Related]
25. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the effector T-cell response and viremia in symptomatic chronic hepatitis C.
Mosnier JF; Pham BN; Scoazec JY; Dubois S; Marcellin P; Martinot-Peignoux M; Degos F; Erlinger S; Degott C
Arch Pathol Lab Med; 1998 May; 122(5):416-22. PubMed ID: 9593342
[TBL] [Abstract][Full Text] [Related]
27. Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus.
Fournillier A; Freida D; Defrance T; Merle P; Trépo C; Inchauspé G
J Med Virol; 2004 Apr; 72(4):566-74. PubMed ID: 14981759
[TBL] [Abstract][Full Text] [Related]
28. T-bet
Liu Y; Zhou S; Qian J; Wang Y; Yu X; Dai D; Dai M; Wu L; Liao Z; Xue Z; Wang J; Hou G; Ma J; Harley JB; Tang Y; Shen N
Arthritis Res Ther; 2017 Oct; 19(1):225. PubMed ID: 28982388
[TBL] [Abstract][Full Text] [Related]
29. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver.
Curry MP; Golden-Mason L; Doherty DG; Deignan T; Norris S; Duffy M; Nolan N; Hall W; Hegarty JE; O'Farrelly C
J Hepatol; 2003 May; 38(5):642-50. PubMed ID: 12713876
[TBL] [Abstract][Full Text] [Related]
30. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.
Doi H; Iyer TK; Carpenter E; Li H; Chang KM; Vonderheide RH; Kaplan DE
Hepatology; 2012 Mar; 55(3):709-19. PubMed ID: 21932384
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia.
Cramp ME; Carucci P; Rossol S; Chokshi S; Maertens G; Williams R; Naoumov NV
Gut; 1999 Mar; 44(3):424-9. PubMed ID: 10026332
[TBL] [Abstract][Full Text] [Related]
32. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
[TBL] [Abstract][Full Text] [Related]
33. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
34. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
[TBL] [Abstract][Full Text] [Related]
35. Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection.
Sugalski JM; Rodriguez B; Moir S; Anthony DD
J Immunol; 2010 Sep; 185(5):3019-27. PubMed ID: 20656924
[TBL] [Abstract][Full Text] [Related]
36. Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.
Moorman J; Dong ZP; Ni L; Zhang C; Borthwick T; Yao ZQ
Immunology; 2009 Oct; 128(2):227-35. PubMed ID: 19740379
[TBL] [Abstract][Full Text] [Related]
37. Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity.
Terrier B; Joly F; Vazquez T; Benech P; Rosenzwajg M; Carpentier W; Garrido M; Ghillani-Dalbin P; Klatzmann D; Cacoub P; Saadoun D
J Immunol; 2011 Dec; 187(12):6550-63. PubMed ID: 22084433
[TBL] [Abstract][Full Text] [Related]
38. Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.
Zarife MA; Reis EA; Carmo TM; Lopes GB; Brandão EC; Silva HR; Santana N; Martins-Filho OA; Reis MG
J Med Virol; 2009 Jan; 81(1):49-59. PubMed ID: 19031471
[TBL] [Abstract][Full Text] [Related]
39. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H
Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
[TBL] [Abstract][Full Text] [Related]
40. Differential expansion of T-cell receptor variable beta subsets after antigenic stimulation in patients with different outcomes of hepatitis C infection.
Woitas RP; Sippel M; Althausen EM; Brackmann HH; Kochan B; Matz B; Rockstroh JK; Sauerbruch T; Spengler U
Immunology; 2002 Jul; 106(3):419-27. PubMed ID: 12100731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
